Optimization of drug delivery systems could also be used to effectively deliver Piezo1 inhibitors to CNS tumor sites through nanotechnology or other advanced drug delivery systems, thereby improving the precision and effectiveness of treatment. This evidence concerns the gene PIEZO1 and neoplasm.